Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 7 Sept 2026Clinical review pending
Saved on this device
!
Apnoea or obstruction during sedation
Loss of chest movement, obstructive noise or an absent capnography waveform can indicate failed ventilation before oxygen saturation falls.
Action: Stop sedative administration and the procedure, call for help, open the airway and provide oxygen with assisted ventilation when needed, while checking the patient and equipment together.
Synopsis
Select an appropriate sedation plan, prepare personnel and rescue equipment, titrate medicines safely and verify recovery before discharge.
Sedation can become deeper than intended; the team must be able to recognise and rescue airway or cardiovascular compromise.
Use a dedicated sedation clinician, a separate procedural clinician and a trained nurse in an appropriately equipped area.
Assess the airway, physiological reserve, aspiration risk, prior drug doses and the procedure’s urgency before selecting an agent.
Investigation priorities
01
Focused pre-sedation assessmentFirst step
Establish suitability, consent and the safest setting.
Management branches
Worked caseA shoulder reduction interrupted by apnoea
A healthy adult undergoing shoulder reduction has received titrated propofol with a separate sedation clinician present. The capnography waveform disappears and there is no visible respiratory effort, while SpO2 is still 98% on oxygen.
Treat the absent effort as apnoea. Stop propofol and pause the reduction immediately; ask for help while the sedation clinician maintains responsibility for the airway.
Open the airway, use appropriate adjuncts and provide bag-mask ventilation with oxygen. Check the capnography line in parallel, but do not let an equipment check delay ventilating a non-breathing patient.
Key medicines
Propofol for adult procedural sedationThe UK 1% product describes 0.5–1 mg/kg IV over 1–5 minutes for onset, titrated to response. RCEM recommends substantially smaller, slowly given 10–20 mg increments in older adults; allow effect before additional dosing.It provides no analgesia and can cause apnoea and hypotension. Reduce dose and speed with frailty, poor cardiac reserve or prior opioids; stop dosing at excessive depth or physiological compromise. Check product-specific allergy contraindications.
Midazolam for conscious sedationUsing 1 mg/mL injection, the UK SmPC starts adults under 60 at 2–2.5 mg IV, given slowly, with 1 mg increments if needed. In older, debilitated or chronically ill adults start 0.5–1 mg and titrate cautiously in 0.5–1 mg increments.Allow time for the evolving effect; the SmPC places initial administration 5–10 minutes before the procedure. It is not an analgesic. Opioids, renal or hepatic impairment and respiratory disease increase risk of prolonged or excessive sedation.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 7 Sept 2026; clinical approval remains outstanding.